FILE PHOTO: Kathy Thomas, far left, holds a “abortion is healthcare” sign during the Women's March protest outside of the Federal Courthouse against U.S. District Judge Matthew Kacsmaryk as he hears a motion by anti-abortion groups led by Alliance for Hippocratic Medicine to pull mifepristone, a drug used in medication abortion, off the market in Amarillo, Texas, U.S., March 15, 2023. REUTERS/Annie Rice /File Photo 

A patient prepares to take mifepristone, the first pill given in a medical abortion, at Women's Reproductive Clinic of New Mexico in Santa Teresa, U.S., January 13, 2023. The abortion clinic, less than a mile from Texas, where abortion is illegal since the landmark legal case Roe v. Wade which protected a woman's constitutional right to an abortion was overturned, provides medical abortions for women who are flying and driving hundreds of miles across Texas. REUTERS/Evelyn Hockstein 

Boxes of mifepristone, the first pill given in a medical abortion, are prepared for patients at Women's Reproductive Clinic of New Mexico in Santa Teresa, U.S., January 13, 2023. The abortion clinic, less than a mile from Texas, where abortion is illegal since the landmark legal case Roe v. Wade which protected a woman's constitutional right to an abortion was overturned, provides medical abortions for women who are flying and driving hundreds of miles across Texas. REUTERS/Evelyn Hockstein 

Dr. Franz Theard watches a patient take mifepristone, the first medication in a medical abortion at his clinic, Women's Reproductive Clinic of New Mexico, in Santa Teresa, U.S., January 13, 2023. The abortion clinic, less than a mile from Texas, where abortion is illegal since the landmark legal case Roe v. Wade which protected a woman's constitutional right to an abortion was overturned, provides medical abortions for women who are flying and driving hundreds of miles across Texas. REUTERS/Evelyn Hockstein 

Dr. Franz Theard watches a patient from Texas take mifepristone, the first medication in a medical abortion, with medical assistant Elizabeth Hernandez, at his clinic, Women's Reproductive Clinic of New Mexico in Santa Teresa, U.S., January 13, 2023. The abortion clinic, less than a mile from Texas, where abortion is illegal since the landmark legal case Roe v. Wade which protected a woman's constitutional right to an abortion was overturned, provides medical abortions for women who are flying and driving hundreds of miles across Texas. REUTERS/Evelyn Hockstein 

Elizabeth Hernandez, a medical assistant at Women's Reproductive Clinic of New Mexico in Santa Teresa, U.S., prepares mifepristone, the first medication in a medical abortion for a patient, January 13, 2023. The abortion clinic, less than a mile from Texas, where abortion is illegal since the landmark legal case Roe v. Wade which protected a woman's constitutional right to an abortion was overturned, provides medical abortions for women who are flying and driving hundreds of miles across Texas. REUTERS/Evelyn Hockstein 

Dr. Franz Theard watches a patient take mifepristone, the first medication in a medical abortion, at Women's Reproductive Clinic of New Mexico, in Santa Teresa, U.S., January 13, 2023. The abortion clinic, owned by Dr. Theard, is less than a mile from Texas where abortion is illegal since Roe v. Wade was overturned, provides medical abortions for women who are flying and driving hundreds of miles across Texas. REUTERS/Evelyn Hockstein 

Used boxes of Mifepristone pills, the first drug used in a medical abortion, fill a trash at Alamo Women's Clinic in Albuquerque, New Mexico, U.S., January 11, 2023. REUTERS/Evleyn Hockstein 

Used boxes of Mifepristone pills, the first drug used in a medical abortion, fill a trash at Alamo Women's Clinic in Albuquerque, New Mexico, U.S., January 11, 2023. REUTERS/Evleyn Hockstein 

Used boxes of Mifepristone pills, the first drug used in a medical abortion, fill a trash at Alamo Women's Clinic in Albuquerque, New Mexico, U.S., January 11, 2023. REUTERS/Evleyn Hockstein 

Used boxes of Mifepristone pills, the first drug used in a medical abortion, fill a trash at Alamo Women's Clinic in Albuquerque, New Mexico, U.S., January 11, 2023. REUTERS/Evleyn Hockstein 

Vicki Saporta, the Executive Director of the National Abortion Federation, speaks at a news conference called by Danco Labratories, in New York, September 28, 2000. The news conference followed the Federal Drug Administration's (FDA) approval of the drug Mifeprex (Mifepristone) the early option abortion pill for women. Danco Labratories has been granted exclusive liscense to manufacture, market and distribute Mifeprex in the United States. 

Gloria Feldt, President of the Planned Parenthood Federation of America, speaks at a press conference called by Danco Labratories in New York, September 28, 2000. The press conference followed the Federal Drug Administration's (FDA) approval of the drug Mifeprex (Mifepristone), the early option abortion pill for women. Danco Labratories has been granted exclusive license from the Population Council to manufacture, market and distribute Mifeprex in the United States. 

Dr. Richard U. Hausknecht OB/GYN, Medical Director of Danco Labratories, speaks at a press conference called by Danco Labratories in New York, September 28, 2000. The press conference followed the Federal Drug Administration's (FDA) approval of the drug Mifeprex (Mifepristone), the early option abortion pill for women. Danco Labratories, under the direction of Dr. Hausknecht, has been granted exclusive license from the Population Council to manufacture, market and distribute Mifeprex in the United States. 

Gloria Feldt (R), President of the Planned Parenthood Federation of America and Dr. Richard U. Hausknecht OB/GYN, Medical Director of Danco Labratories smile as they listen to a speaker at a press conference called by Danco Labratories in New York, September 28, 2000. The press conference followed the Federal Drug Administration's (FDA) approval of the drug Mifeprex (Mifepristone), the early option abortion pill for women. Danco Labratories, under the direction of Dr. Hausknecht, has been granted exclusive license from the Population Council to manufacture, market and distribute Mifeprex in the United States. 

Gloria Feldt (R), President of the Planned Parenthood Federation of America and Dr. Richard U. Hausknecht OB/GYN, Medical Director of Danco Labratories smile as they listen to a speaker at a press conference called by Danco Labratories in New York, September 28, 2000. The press conference followed the Federal Drug Administration's (FDA) approval of the drug Mifeprex (Mifepristone), the early option abortion pill for women. Danco Labratories, under the direction of Dr. Hausknecht, has been granted exclusive license from the Population Council to manufacture, market and distribute Mifeprex in the United States.

MS/MMR 

Vicki Saporta (L), Executive Director of the National Abortion Federation and Gloria Feldt (R), President of the Planned Parenthood Federation of America smile as they share a moment together following a news conference at the Academy of Medicine, in New York, September 28, 2000. Both were at the press conference called by Danco Labratories following the Federal Drug Administration's (FDA) approval of the drug Mifeprex (Mifepristone), the early option abortion pill for women.

MS/rcs